These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32288909)

  • 21. Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis.
    de Lima VM; Ikeda FA; Rossi CN; Feitosa MM; Vasconcelos RO; Nunes CM; Goto H
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):296-302. PubMed ID: 20132994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity assay of the Leishmune vaccine against canine visceral leishmaniasis in Brazil.
    Borja-Cabrera GP; Santos FN; Bauer FS; Parra LE; Menz I; Morgado AA; Soares IS; Batista LM; Palatnik-de-Sousa CB
    Vaccine; 2008 Sep; 26(39):4991-7. PubMed ID: 18675868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canine Leishmania vaccines: still a long way to go.
    Gradoni L
    Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas.
    Palatnik-de-Sousa CB; Silva-Antunes I; Morgado Ade A; Menz I; Palatnik M; Lavor C
    Vaccine; 2009 Jun; 27(27):3505-12. PubMed ID: 19464528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi for the Immunotherapy of canine visceral Leishmaniasis.
    Ferreira JH; Silva Ldos S; Longo-Maugéri IM; Katz S; Barbiéri CL
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2729. PubMed ID: 24625516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two commercial vaccines against visceral leishmaniasis in dogs from endemic areas: IgG, and subclasses, parasitism, and parasite transmission by xenodiagnosis.
    Fernandes CB; Junior JT; de Jesus C; Souza BM; Larangeira DF; Fraga DB; Tavares Veras PS; Barrouin-Melo SM
    Vaccine; 2014 Mar; 32(11):1287-95. PubMed ID: 24406392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections.
    Zanin FH; Coelho EA; Tavares CA; Marques-da-Silva EA; Silva Costa MM; Rezende SA; Gazzinelli RT; Fernandes AP
    Microbes Infect; 2007 Jul; 9(9):1070-7. PubMed ID: 17644455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis.
    Borja-Cabrera GP; Santos FN; Santos FB; Trivellato FA; Kawasaki JK; Costa AC; Castro T; Nogueira FS; Moreira MA; Luvizotto MC; Palatnik M; Palatnik-de-Sousa CB
    Vaccine; 2010 Jan; 28(3):597-603. PubMed ID: 19800443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E; Casas CP; Borja-Cabrera GP; Santos FN; Nico D; Souza LO; Tinoco LW; da Silva BP; Palatnik M; Parente JP; Palatnik-de-Sousa CB
    Vaccine; 2006 May; 24(18):3909-20. PubMed ID: 16556475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipophosphoglycan-3 protein from Leishmania infantum chagasi plus saponin adjuvant: A new promising vaccine against visceral leishmaniasis.
    de Oliveira Emerick S; Vieira de Carvalho T; Meirelles Miranda B; Carneiro da Silva A; Viana Fialho Martins T; Licursi de Oliveira L; de Almeida Marques-da-Silva E
    Vaccine; 2021 Jan; 39(2):282-291. PubMed ID: 33309484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine Profile of Leishmania Infantum Fucose-Mannose Ligand in Vaccinated Dogs in the Northwest of Iran.
    Mohammadi-Ghalehbin B; Hatam G; Sarkari B; Mohebali M; Zarei Z; Bohlooli S
    Iran J Immunol; 2017 Dec; 14(4):293-305. PubMed ID: 29276182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine.
    Santos WR; Aguiar IA; Paraguai de Souza E; de Lima VM; Palatnik M; Palatnik-de-Sousa CB
    Vaccine; 2003 Dec; 21(32):4668-76. PubMed ID: 14585674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization of Experimental Dogs With Salivary Proteins From
    Abbehusen MMC; Cunha J; Suarez MS; Teixeira C; Almeida VDA; Pereira LDS; Bordoni M; Gil-Santana L; Solcà MDS; Fraga DBM; Fischer L; Bozza PT; Veras PST; Valenzuela JG; Kamhawi S; Andrade BB; Brodskyn CI
    Front Immunol; 2018; 9():2558. PubMed ID: 30519235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.
    Shahbazi M; Zahedifard F; Taheri T; Taslimi Y; Jamshidi S; Shirian S; Mahdavi N; Hassankhani M; Daneshbod Y; Zarkesh-Esfahani SH; Papadopoulou B; Rafati S
    PLoS One; 2015; 10(7):e0132794. PubMed ID: 26197085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Live attenuated Leishmania infantum centrin deleted mutant (LiCen
    Zarei Z; Mohebali M; Dehghani H; Khamesipour A; Tavakkol-Afshari J; Akhoundi B; Abbaszadeh-Afshar MJ; Alizadeh Z; Eskandari SE; Asl AD; Razmi GR
    Comp Immunol Microbiol Infect Dis; 2023 Jun; 97():101984. PubMed ID: 37119594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the monoterpene, glycidic and triterpene-moieties' contributions to the adjuvant function of the CP05 saponin of Calliandra pulcherrima Benth during vaccination against experimental visceral leishmaniasis.
    Nico D; Santos FN; Borja-Cabrera GP; Palatnik M; Palatnik de Sousa CB
    Vaccine; 2007 Jan; 25(4):649-58. PubMed ID: 17014936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.
    de Andrade RA; Reis AB; Gontijo CM; Braga LB; Rocha RD; Araújo MS; Vianna LR; Martins-Filho OA
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):85-97. PubMed ID: 17287029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs.
    Fiuza JA; Santiago Hda C; Selvapandiyan A; Gannavaram S; Ricci ND; Bueno LL; Bartholomeu DC; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2013 Apr; 31(14):1785-92. PubMed ID: 23398933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis using canine peripheral blood for establishing in vitro conditions for monocyte differentiation into macrophages for Leishmania chagasi infection and T-cell subset purification.
    Viana KF; Aguiar-Soares RD; Roatt BM; Resende LA; da Silveira-Lemos D; Corrêa-Oliveira R; Martins-Filho OA; Moura SL; Zanini MS; Araújo MS; Reis AB; Giunchetti RC
    Vet Parasitol; 2013 Nov; 198(1-2):62-71. PubMed ID: 24018185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis.
    Resende LA; Roatt BM; Aguiar-Soares RD; Viana KF; Mendonça LZ; Lanna MF; Silveira-Lemos D; Corrêa-Oliveira R; Martins-Filho OA; Fujiwara RT; Carneiro CM; Reis AB; Giunchetti RC
    Vet Parasitol; 2013 Dec; 198(3-4):371-81. PubMed ID: 24129068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.